Coverage
-
March 11, 2013
A Massachusetts federal judge on Friday upheld a jury's verdict that found two antibody patents held by Abbott GmbH & Co. KG were invalid, finalizing a courtroom win for Johnson & Johnson subsidiary Janssen Biotech Inc.
2 other articles on this case.
View all »